165 related articles for article (PubMed ID: 16112950)
1. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
Santen R
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
3. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.
Harvey JA; Santen RJ; Petroni GR; Bovbjerg VE; Smolkin ME; Sheriff FS; Russo J
Menopause; 2008; 15(1):67-73. PubMed ID: 17558338
[TBL] [Abstract][Full Text] [Related]
4. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
6. Use of hormone therapy and isoflavones and mammographic density in Spain.
Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
[TBL] [Abstract][Full Text] [Related]
7. The role of mammographic density in evaluating changes in breast cancer risk.
Pike MC
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():1-5. PubMed ID: 16112948
[TBL] [Abstract][Full Text] [Related]
8. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
9. [Breast density: a major parameter to follow during hormone replacement therapy].
Gairard B; Guldenfels C; Haehnel P; Mathelin C
Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
[TBL] [Abstract][Full Text] [Related]
10. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and mammographic density.
Kilicdag EB; Bagis T; Pourbagher A; Tarim E
Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
[No Abstract] [Full Text] [Related]
12. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
[TBL] [Abstract][Full Text] [Related]
13. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
Aiello EJ; Buist DS; White E
Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
[TBL] [Abstract][Full Text] [Related]
14. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
15. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy, mammographic density, and breast cancer risk.
Martin LJ; Minkin S; Boyd NF
Maturitas; 2009 Sep; 64(1):20-6. PubMed ID: 19709825
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen-progestin and estrogen on mammographic density.
Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
[TBL] [Abstract][Full Text] [Related]
18. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes.
Yaghjyan L; Tamimi RM; Bertrand KA; Scott CG; Jensen MR; Pankratz VS; Brandt K; Visscher D; Norman A; Couch F; Shepherd J; Fan B; Chen YY; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
Breast Cancer Res Treat; 2017 Sep; 165(2):421-431. PubMed ID: 28624977
[TBL] [Abstract][Full Text] [Related]
19. [Mammographic breast density and breast cancer risk during HRT].
Bock K; Hadji P; Duda VF; Jackisch C; Wagner U
Zentralbl Gynakol; 2005 Aug; 127(4):217-21. PubMed ID: 16037902
[TBL] [Abstract][Full Text] [Related]
20. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
